To use all functions of this page, please activate cookies in your browser.
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
National Physicians Alliance
The National Physicians Alliance (NPA) is a national, multi-specialty medical organization founded in 2005 by former leaders of the American Medical Student Association. The primary goal of the NPA is re-establish the professionalism in medicine through “service, integrity, and advocacy.” Product highlightThe National Physicians Alliance has a membership of approximately 10,000 physicians. Membership is limited to physicians (MD and DO) in the United States. The NPA is a 501c(6) organization based in Reston, Virginia. The NPA Foundation, a 501c(3) entity, was established in 2007. The NPA does not accept money from the pharmaceutical industry. The NPA was founded in part in response to criticism that professional medical organizations, particularly the AMA, act as physician guilds primarily serving the economic interests of physicians rather than patients and public health. To ensure that the NPA continues to work on behalf of patients, the organizational structure includes a Council of Consumers, consisting of patient advocacy organizations to advise the NPA Board. The Council of Consumers currently consists of representatives from the National Council of La Raza, The AIDS Institute, Universal Health Care Action Network, and Families USA[1]. The current president of the NPA is Lydia Vaias, MD, a general surgeon in California. The Executive Director is Jean Silver-Isenstadt, MD, PhD. The 2008 Annual Meeting will be held in Houston, Texas in March 2008. Notes
|
||||||||||||||||||||||
This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "National_Physicians_Alliance". A list of authors is available in Wikipedia. |
- DB Biotech, spol. s r.o. - Kosice, Chequia
- New model developed to study inflammatory bowel disease in human biopsy samples
- CryoLife Awarded U. S. Patent for BioFoam - Potential Product Applications Include Battlefield Injuries, Internal Organ and Vascular Tissue Sealing, and Tissue Augmentation
- Innogenetics acquires therapeutic vaccine program of Genencor - Innogenetics strengthens therapeutic vaccine pipeline in the fields of hepatitis B, human papillomavirus, and hepatitis C
- Testing the Efficacy of New Gene Therapies More Efficiently